0
2020
Oral Antibiotics Market

Oral Antibiotics Market

By Class (Beta lactam & beta lactamase inhibitors, Quinolones, Macrolide, and Others), Application (Community-Acquired Respiratory Tract Infections (CARTIS), Urinary Tract Infections (UTIS), Dental, and Others), Drug Origin (Natural, Semisynthetic, Synthetic), Spectrum Of Activity (Broad-Spectrum Antibiotic, Mid/Narrow-Spectrum Antibiotic), Drug Type (Branded And Generics): Global Opportunity Analysis and Industry Forecast, 2020-2027

Report Code: A06540
Pages: 329
Jun 2020 | 6171 Views
Author(s) : Surabhi P , Onkar S
Tables: 190
Charts: 62
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Oral Antibiotics Market

Request Now !

The global oral antibiotics market generated $18,365.80 million in 2018, and is projected to reach $23,306.10 million by 2027, growing at a CAGR of 2.7% from 2019 to 2027.

Antibiotic is an antimicrobial substance or a compound that fights against bacterial infections and sometimes with protozoan infections, but not viral infections. These are medications that either stop bacteria from growing or kill bacteria directly, referred as bacteriostatic and bactericidal antibiotics, respectively. There are several types of antibiotics easily available at drug stores and in hospitals with a prescription or without a prescription in most countries. Antibiotics are mostly used during transplants, dialysis, suppressed immune system, and joint replacement.

oral-antibiotics-market-2020-2027-1593695261

The virus that causes COVID-19 is from the family of viruses called Coronaviridae and antibiotics do not work against them. However, some people who are affected by Covid-19 can also develop a bacterial infection as a complication. In this case, health care providers recommend antibiotics. Hence, the impact of Covid-19 on oral antibiotics industry is expected to be moderate.

There is an increase in demand for antibiotics, owing to increased consumption in low- and middle-income countries (LMICs) and rise in prevalence of infectious diseases. In addition, development of novel approaches for new antibiotics to treat bacterial infections and large number of clinical trials further drive the market growth. However, development of antibiotic resistance, driven by misuse of antibiotics and time taken for regulatory approvals are projected to impede the market growth. On the contrary, discovery of advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections are expected to offer significant profitable opportunities for the market players.

The global oral antibiotics market is segmented on the basis of class, application, drug origin, spectrum of activity, drug type, and region. On the basis of class, it is classified into beta lactam & beta lactamase inhibitors, quinolones, macrolides, and others. Beta lactam & beta lactamase inhibitors is further segmented into Penicillin, Cephalosporin, and others. By application, the market is divided into community- respiratory tract infections (CARTIS), urinary acquired tract infections (UTIS), dental, and others. Depending on drug origin, it is categorized into natural, semisynthetic, and synthetic. According to the spectrum of activity, it is bifurcated into broad-spectrum antibiotic and narrow-spectrum antibiotic. By drug type, it is divided into branded and generics. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the global oral antibiotics market include Abbott Laboratories, Allergan Plc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck & Co. Inc., Mylan N.V., Novartis International AG (Sandoz), Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Ltd.

Segment review

Depending on class, the market is categorized into the beta lactam & beta lactamase inhibitors segment was the highest contributor to the market in 2018.  The segment is the major revenue contributor, owing to its broad-spectrum of activity. A broad-spectrum antibiotic fights both gram-negative and gram-positive bacteria as well as is effective on the multiple groups of bacterial infections. However, quinolone segment is expected to witness highest CAGRs during the forecast period, owing to its broad spectrum of activity and they are effective against a wide range of bacteria. 

Oral Antibiotics Market
By Class

Your browser does not support the canvas element.

Beta lactam & beta lactamase inhibitors is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

On the basis of application, the CARTIs segment is further segmented into upper respiratory tract infections (URTI) and lower respiratory tract infections (LRTI). The dental segment is further divided into combination and monotherapies. The urinary acquired tract infections segment was the highest contributor to the market in 2018, and expected to witness CAGR of 2.0% during the forecast period, as it is the most common hospital acquired infection accounting for almost 40% of all nosocomial infections and females are more likely to acquire UTI every year as compared to males. In addition, diabetic patients are also more prone to UTIs, mostly owing to abnormalities in immune function.

Oral Antibiotics Market
By Application

Your browser does not support the canvas element.

The UTIs segment generated the highest revenue in 2018, and is anticipated to maintain its dominance throughout the forecast period.

Get more information on this report : Request Sample Pages

On the basis of drug origin, the oral antibiotics market is classified into natural, semisynthetic and synthetic. The synthetic segment generated highest revenue in 2018, and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the fact that semisynthetic oral antibiotics have improved coverage and effectiveness against a wide range of organisms. However, the synthetic segment is projected to show fastest growth during the forecast period, due to the rising need of synthetic membrane-targeted antibiotics due to the antimicrobial resistance. The synthetic antibiotics have various advantages over existing antibiotics such as a broad spectrum of activity, no cross-resistance with the existing antibiotics, rapid bactericidal activity, and a low probability for developing resistance.

Oral Antibiotics Market
By Drug Origin

Your browser does not support the canvas element.

The synthetic segment generated highest revenue in 2018, and is anticipated to maintain its dominance throughout the forecast period.

Get more information on this report : Request Sample Pages

Region wise, Asia-Pacific accounted for nearly two-fifths of the global market share in 2018 and is expected to remain dominant throughout the forecast period. This region is the world’s largest consumer of antibiotics, owing to large number of antibiotics consumption, easy availability of antibiotics, and rise in sales of antibiotics without prescription. However, LAMEA is expected to experience the highest growth rate during the forecast period. This is attributed to easy obtainability of over-the-counter antibiotics as well as there are no legislations or restrictions on their use in this region.

Oral Antibiotics Market
By Region

2027
Asia-pacific 
North America
Europe
LAMEA

Asia-Pacific accounted for nearly two-fifths of the global market share in 2018 and is expected to remain dominant throughout the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global oral antibiotics market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2018 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities. 
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global oral antibiotics market growth.

Oral Antibiotics Market Report Highlights

Aspects Details
By Class
  • Beta Lactam and Beta Lactamase Inhibitors
    • Penicillin
    • Broad-spectrum penicillin
    • Mid/Narrow Spectrum Penicillin
    • Cephalosporin
    • Others
  • Quinolone
  • Macrolide
  • Others
By Application
  • Community-acquired respiratory tract infections (CARTIs)
    • Upper Respiratory Tract Infections (URTI)
    • Lower Respiratory Tract Infections (LRTIs)
  • Urinary tract infections (UTIs)
  • Dental
    • Combination
    • Monotherapies
  • Others
By DRUG ORIGIN
  • Natural
  • Semisynthetic
  • Synthetic
By Spectrum Of Activity
  • Broad-spectrum Antibiotic
  • Mid/Narrow-spectrum antibiotic
By DRUG TYPE
  • Branded
  • Generics
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, Spain, Italy, UK, Russia, Rest of Europe)
  • Asia-Pacific  (Japan, India, China, Pakistan, Vietnam, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Turkey, Rest of LAMEA)
Key Market Players GLAXOSMITHKLINE PLC, MERCK & CO., INC., PFIZER INC., NOVARTIS INTERNATIONAL AG (PEAR THERAPEUTICS, INC.), MYLAN N.V., SANOFI, TEVA PHARMACEUTICAL INDUSTRIES LTD., F. HOFFMANN-LA ROCHE LTD., ABBOTT LABORATORIES, ALLERGAN PLC
 

Loading Table Of Content...


 
 

This section provides various opinions of top-level CXOs in the oral antibiotics market. According to several interviews conducted, the field of oral antibiotics is gaining popularity, owing to its ease of use and convenience for patients. 

As per CXOs, rise in infectious diseases, growth in initiatives by pharma companies to enhance antibiotics R&D, and technological innovations in oral antibiotics significantly boost the growth of the oral antibiotics market. However, development of antibiotic resistance, driven by misuse of antibiotics, and increase in drug approval costs are expected to hinder the market growth.

In addition, rise in consumption of antibiotics in low and middle-income countries (LMICs), increase in prevalence of infectious diseases, development of novel approaches for new antibiotics to treat bacterial infections, and large number of clinical trials are projected to drive the market growth during the forecast period. 

The CXOs further added that the market is saturated and is growing at a steady rate in developed nations. Asia-Pacific is expected to remain dominant during the forecast period, owing to increase in consumption of antibiotics, lower cost of antibiotics, and high prevalence of bacterial infections in developing countries. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, owing to rise in antimicrobial resistance, which leads pharmaceutical companies toward R&D for next generation antibiotics. In addition, wide availability of advanced systems supplements the growth of the market. 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total value of oral antibiotics market was $ 18,861.70 million in 2019.

A. The forecast period in the report is from 2020-2027.

A. The market value of oral antibiotics market in 2020 was $24,256.10 million.

A. The base year calculated is 2018 in the report.

A. As per the key industry leaders, rise in incidence of infectious diseases cases, Increase in consumption in low-and middle-income countries (LMICs)increasing R&D initiatives to develop novel technologies and Development of novel approaches will drive the oral antibiotics market

A. Development of novel approaches in the market is expected to drive the market growth during the forecast period.

A. The growth % of the Autoinjectors market is 2.7%.

A. Beta lactam and lactamase inhibitors segment holds the maximum market share.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Oral Antibiotics Market

Start reading instantly.
This Report and over 54,961+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,840
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jun 2021 - Jun 2022)
  • Data Pack
  • $4,380
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2021 - Jun 2022)
  • Single User
  • $6,090
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2021 - Jun 2022)
  • Five Users
  • $6,630
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2021 - Jun 2022)
  • Enterprise
    License/PDF

  • $10,500
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2021 - Jun 2022)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers